A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Transcatheter aortic-valve replacement (TAVR) for the treatment of aortic stenosis can lead to embolization of debris. Capture of debris by devices that provide cerebral embolic protection (CEP) may ...
CHICAGO, IL—A large-scale, randomized trial testing routine cerebral embolic protection during TAVI has once again failed to show the device reduces the risk of stroke. The two trials, which in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results